Literature DB >> 312626

T cells in ankylosing spondylitis.

D Sotnik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 312626      PMCID： PMC1000357          DOI： 10.1136/ard.38.2.199-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Objective evaluation of patients with rheumatic diseases. I. Comparison of serum glycoprotein, cold hemagglutination, C-reactive protein, and other tests with clinical evaluation.

Authors:  M R SHETLAR; R W PAYNE; J PADRON; F FELTON; W K ISHMAEL
Journal:  J Lab Clin Med       Date:  1956-08

2.  The measurement of C-reactive protein in human sera; comparison of the clinical tests on the basis of a quantitative method.

Authors:  H F WOOD; M McCARTY
Journal:  J Clin Invest       Date:  1951-06       Impact factor: 14.808

3.  Lymphocyte abnormalities in ankylosing spondylitis.

Authors:  P T Fan; P J Clements; D T Yu; G Opelz; R Bluestone
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

4.  Binding of C-reactive protein to antigen-induced but not mitogen-induced T lymphoblasts.

Authors:  S M Croft; R F Mortensen; H Gewurz
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

5.  Lymphocytes binding C-reactive protein during acute rheumatic fever.

Authors:  R C Williams; K A Kilpatrick; M Kassaby; Z H Abdin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

6.  Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions.

Authors:  R F Mortensen; A P Osmand; H Gewurz
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307
  6 in total
  1 in total

1.  T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.

Authors:  N Feltelius; R Hällgren; O Sjöberg
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.